4.8 Article

Sequential PDT and PTT Using Dual-Modal Single-Walled Carbon Nanohorns Synergistically Promote Systemic Immune Responses against Tumor Metastasis and Relapse

期刊

ADVANCED SCIENCE
卷 7, 期 16, 页码 -

出版社

WILEY
DOI: 10.1002/advs.202001088

关键词

immunotherapy; photodynamic therapy; photoimmunotherapy; photothermal therapy; single-walled carbon nanohorns; tumor metastases

资金

  1. National Natural Science Foundation of China [81571729, 81772338, 81930069, 81802979, 81800585]
  2. Med-Engineering Crossing Foundation from Shanghai Jiao Tong University [YG2017ZD05]
  3. Innovation Research Plan [2019-01-07-00-02-E00064, ZXWF082101]
  4. Three-year Talents Program of Changzheng Hospital (2018)

向作者/读者索取更多资源

Immune responses stimulated by photodynamic therapy (PDT) and photothermal therapy (PTT) are a promising strategy for the treatment of advanced cancer. However, the antitumor efficacy by PDT or PTT alone is less potent and unsustainable against cancer metastasis and relapse. In this study, Gd(3+)and chlorin e6 loaded single-walled carbon nanohorns (Gd-Ce6@SWNHs) are developed, and it is demonstrated that they are a strong immune adjuvant, and have high tumor targeting and penetration efficiency. Then, three in vivo mouse cancer models are established, and it is found that sequential PDT and PTT using Gd-Ce6@SWNHs synergistically promotes systemic antitumor immune responses, where PTT stimulates dendritic cells (DCs) to secrete IL-6 and TNF-alpha, while PDT triggers upregulation of IFN-gamma and CD80. Moreover, migration of Gd-Ce6@SWNHs from the targeted tumors to tumor-draining lymph nodes sustainably activates the DCs to generate a durable immune response, which eventually eliminates the distant metastases without using additional therapeutics. Gd-Ce6@SWNHs intervened phototherapies also generate durable and long-term memory immune responses to tolerate and prevent cancer rechallenge. Therefore, this study demonstrates that sequential PDT and PTT using Gd-Ce6@SWNHs under moderate conditions elicits cooperative and long-lasting antitumor immune responses, which are promising for the treatment of patients with advanced metastatic cancers.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据